万赛维医保报销多少？

Cytomegalovirus infection is a common complication after organ transplantation, with an incidence rate as high as 50%. The pain caused by organ rejection, cardiovascular disease, post-transplantation diabetes and related treatments has seriously affected the quality of life of patients. (valcyte) is an oral anti-cytomegalovirus infection drug that combines the advantages of oral administration and intravenous injection. Just taking 2 tablets of Valcyte per day can effectively prevent and treat cytomegalovirus infection, avoid the direct and indirect harm caused by cytomegalovirus infection, and significantly improve the patient's quality of life and long-term survival rate.

In clinical trials, among patients who received Vancevir tablets or intravenous ganciclovir induction therapy followed by Vancevir tablets for maintenance treatment, the average time (median time) from randomization to CMV retinitis exacerbation was: 226 (160) days and 219 (125) days.

In August 2006, valcyte was launched in China with a specification of 450mg*60 tablets/box and a relatively high price of $16,500/box. And unfortunately, Vancevi is not covered by my country’s medical insurance, so patients cannot be reimbursed by medical insurance and can only buy it at the original price.

Medical Travel learned that Roche’s Valgancilovir (valgancilovir hydrochloride tablets, 450mg*60 tablets) sells for about RMB 5,500 in Indian pharmacies. This undoubtedly greatly reduces the financial pressure on patients. Patients who are inconvenient to go abroad to purchase can choose to purchase through Medical Companion Travel.

It is an oral medication and should be taken with food. The recommended dose for induction treatment of CMV retinitis in adults is 900 mg (two 450 mg tablets) twice daily for 21 days. Prolonged induction therapy may increase the risk of bone marrow toxicity. After induction therapy, or in patients with inactive CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) once daily. Induction therapy may be repeated in patients with worsening retinitis.